Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hamburg Says Rhetoric Over FDA's Effect On Innovation Could Harm Regulatory Process

This article was originally published in The Pink Sheet Daily

Executive Summary

In a speech to the consumer group Public Citizen, FDA Commissioner Margaret Hamburg says the increasingly heated complaints that the agency is stifling medical product development could undermine public confidence in regulatory standards and approved products.

You may also be interested in...



FDA's "Entrepreneurs-In-Residence" Program Aims To Help Small Companies

New FDA measures aimed at helping small businesses navigate the regulatory review process are part of the agency’s larger counter-attack against claims that it is creating a drag on medical product innovation.

FDA's "Entrepreneurs-In-Residence" Program Aims To Help Small Companies

New FDA measures aimed at helping small businesses navigate the regulatory review process are part of the agency’s larger counter-attack against claims that it is creating a drag on medical product innovation.

FDA Approval Standards Need To Be Relaxed, Venture Capitalists Say

FDA should accept “a reasonable likelihood of patient benefit” as the appropriate standard for approving therapies for unmet medical needs, the National Venture Capital Association and its Medical Innovation & Competitiveness Coalition contend.

Related Content

Topics

UsernamePublicRestriction

Register

MT125529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel